Despite the improvement of several aspects, we have not yet reached satisfactory glycemic control of in-hospital hyperglycemia and much remains to be done, namely with regard to the use of the sliding scale insulin regimen particularly if long-term, in which case it stands out for low efficiency and potential harms ( 24 , 25 ). The gene discussed is INS; the disease is Hyperglycemia.